Hepion Pharmaceuticals Inc (HEPA)

[Fress]

Major & Emerging Players in Liver Cirrhosis Market:-

F.Hoffmann-La Roche AG (Switzerland),Merck & Co., Inc (United States),Abbott Laboratories (United States),Novartis International AG (Switzerland),Bristol Myers Squibb Company (United States),Gilead Sciences, Inc (United States),Conatus Pharmaceuticals (United States),GlaxoSmithKline plc (United Kingdom),Grifols, S.A. (Spain),GWOXI Stem Cell Applied Technology Co., Ltd (China),Hepion Pharmaceuticals (United States),Intercept Pharmaceuticals, Inc. (United States),Lepu Medical Technology (Beijing) Co., Ltd. (China)
https://erxnews.com/news/336525/liver-cirrhosis-market-analysis-major-competitor-and-strategies-regional-outlook-2021-to-2026/

Hepa textbook cup & handle pattern is formed.



Nash Phase 2 & 3 Trials by companies in the space:
AKRO Akero Therapeutics 1.1 Billion Marketcap 240 Million in cash
MDGL Madrigal Pharmaceutical 1.7 Billion Marketcap 300 Million in cash
HEPA Hepion Pharmaceuticals 160 Million market cap 120 million in cash burning under 5 million a quarter



$HEPA